Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.

Tianyi ZhaoYifang ZhangXiaohong MaLina WeiYixin HouRui SunJie Jiang

Published in: Cancer cell international (2021)

These findings suggested that LPCAT1 may act as a valuable prognostic biomarker and be correlated with immune infiltrates in endometrial cancer, which may provide novel therapy options for and improved treatment of EC.

Keyphrases

endometrial cancer
poor prognosis
long non coding rna
stem cells
bone marrow
cell therapy